Allspring Global Investments
IBRX icon

Allspring Global Investments’s ImmunityBio IBRX Stock Holding History

Allspring Global Investments’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73.1K Buy
+10,189
New +$69.8K ﹤0.01% 1657
2022
Q2 		– Sell
-124,998
Closed -$701K – 2800
2022
Q1 		$701K Sell
124,998
-3,556
-3% -$21.8K ﹤0.01% 2072
2021
Q4 		$781K Buy
+128,554
New +$966K ﹤0.01% 2085

Other funds holding IBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Allspring Global Investments's IBRX Position: Q1 2026 in Review

Allspring Global Investments opened a new position in ImmunityBio (IBRX) in Q1 2026: 10,189 shares worth $73.1K. The stake represents ﹤0.01% of the portfolio and ranks #1657 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in IBRX as recently as Q1 2022.

Allspring Global Investments first reported a position in IBRX in Q4 2021 and has held it in 3 quarters since. The position peaked at $781K in Q4 2021. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • Allspring Global Investments held 10,189 shares of ImmunityBio worth $73.1K as of Q1 2026.
  • ImmunityBio was a new Allspring Global Investments position in Q1 2026.
  • ImmunityBio made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1657 holding.
  • Allspring Global Investments first reported a position in ImmunityBio in Q4 2021 and has held it in 3 quarters since.
  • Allspring Global Investments's ImmunityBio position peaked at $781K in Q4 2021.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.